Maximizing Commercial Outcomes for Oncology Medicines

We see what’s possible and bring it to market

Recent News & Events

View All
Secura Bio Presents Extended Follow Up Analyses from Phase 2 PRIMO Trial in Patients with Relapsed/Refractory peripheral T-cell lymphoma at the 2025 American Society of Hematology Meeting Dec 07, 2025 Press Release
Secura Bio to Participate in the Jefferies Global Healthcare Conference in London Nov 05, 2025 Press Release
Back to top